Total Assets
The latest quarterly total assets is $2.99B with a quarterly period change of (6.37%). Total assets represent the full value of resources controlled by the company, including current assets, property, equipment, and intangible assets.
PODD Total Assets
Reported quarterly total assets; no daily interpolation.
Quarterly Total Assets History
| Period | Total Assets | % Change |
|---|---|---|
| Q1 2026 | $2.99B | (6.37%) |
| Q4 2025 | $3.19B | +5.32% |
| Q3 2025 | $3.03B | (12.68%) |
| Q2 2025 | $3.47B | (1.37%) |
| Q1 2025 | $3.52B | +13.91% |
| Q4 2024 | $3.09B | +2.06% |
| Q3 2024 | $3.03B | +4.99% |
| Q2 2024 | $2.88B | +9.82% |
| Q1 2024 | $2.62B | +1.38% |
| Q4 2023 | $2.59B | +4.88% |
| Q3 2023 | $2.47B | +3.43% |
| Q2 2023 | $2.39B | +4.22% |
| Q1 2023 | $2.29B | +1.69% |
| Q4 2022 | $2.25B | +3.92% |
| Q3 2022 | $2.17B | +2.48% |
| Q2 2022 | $2.11B | +2.15% |
| Q1 2022 | $2.07B | +1.00% |
| Q4 2021 | $2.05B | +2.50% |
| Q3 2021 | $2.00B | +3.91% |
| Q2 2021 | $1.92B | +4.54% |
| Q1 2021 | $1.84B | (1.75%) |
| Q4 2020 | $1.87B | +9.49% |
| Q3 2020 | $1.71B | +5.16% |
| Q2 2020 | $1.63B | +46.79% |
| Q1 2020 | $1.11B | (3.04%) |
| Q4 2019 | $1.14B | (9.89%) |
| Q3 2019 | $1.27B | +29.73% |
| Q2 2019 | $977.72M | +2.64% |
| Q1 2019 | $952.61M | +2.57% |
| Q4 2018 | $928.74M | +4.79% |
| Q3 2018 | $886.31M | +5.66% |
| Q2 2018 | $838.86M | +1.10% |
| Q1 2018 | $829.76M | +1.59% |
| Q4 2017 | $816.74M | +63.24% |
| Q3 2017 | $500.35M | +8.93% |
| Q2 2017 | $459.33M | +3.23% |
| Q1 2017 | $444.96M | (2.56%) |
| Q4 2016 | $456.65M | +0.76% |
| Q3 2016 | $453.20M | +72.29% |
| Q2 2016 | $263.05M | +3.25% |
| Q1 2016 | $254.77M | (7.40%) |
| Q4 2015 | $275.13M | (6.14%) |
| Q3 2015 | $293.12M | (2.42%) |
| Q2 2015 | $300.39M | (1.74%) |
| Q1 2015 | $305.72M | +1.18% |
| Q4 2014 | $302.16M | +0.32% |
| Q3 2014 | $301.20M | (7.42%) |
| Q2 2014 | $325.33M | +12.75% |
| Q1 2014 | $288.53M | +0.20% |
| Q4 2013 | $287.95M | (0.53%) |
| Q3 2013 | $289.50M | +1.17% |
| Q2 2013 | $286.15M | +1.87% |
| Q1 2013 | $280.90M | +41.83% |
| Q4 2012 | $198.06M | +3.35% |
| Q3 2012 | $191.64M | (0.16%) |
| Q2 2012 | $191.94M | (5.89%) |
| Q1 2012 | $203.94M | (2.69%) |
| Q4 2011 | $209.58M | (2.87%) |
| Q3 2011 | $215.78M | (4.60%) |
| Q2 2011 | $226.19M | +51.88% |
| Q1 2011 | $148.93M | (4.68%) |
| Q4 2010 | $156.23M | +4.26% |
| Q3 2010 | $149.85M | (7.49%) |
| Q2 2010 | $161.99M | +1.86% |
| Q1 2010 | $159.04M | (7.35%) |
| Q4 2009 | $171.65M | +46.55% |
| Q3 2009 | $117.13M | +17.94% |
| Q2 2009 | $99.31M | (17.14%) |
| Q1 2009 | $119.85M | +9.73% |
| Q4 2008 | $109.23M | (19.29%) |
| Q3 2008 | $135.33M | (12.45%) |
| Q2 2008 | $154.57M | +32.72% |
| Q1 2008 | $116.47M | (10.92%) |
| Q4 2007 | $130.74M | (3.59%) |
| Q3 2007 | $135.60M | (9.08%) |
| Q2 2007 | $149.14M | +212.78% |
| Q1 2007 | $47.68M | (16.55%) |
| Q4 2006 | $57.14M | +27.24% |
| Q3 2006 | $44.91M | +167.43% |
| Q4 2005 | $16.79M | - |
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy